From Regina Schaffer
The European Commission this month unveiled their new chemicals strategy for sustainability, designed to protect the public from exposure to endocrine-disrupting chemicals and their health effects.
The chemicals strategy, part of the European Green Deal, is designed to be the foundation for the biggest update to Europe’s chemical regulations in more than a decade. The chemical strategy commits to a hazard identification for EDCs, including strict measures to prevent their use in consumer products. The strategy also calls for stricter data requirements for EDCs across all relevant legislation and to accelerate the development and adoption of better test methods. In a statement, the Endocrine Society praised the new strategy, and urged “further details and concrete actions” to protect public health.
Healio spoke with Barbara Demeneix, PhD, DSc, chair of the Endocrine Society’s EDC advisory group, about the latest push in Europe to assess EDCs, the risks of combination chemicals and how endocrinologists can become better advocates to rein in EDC use in the United States.